Close Menu

The American Civil Liberties Union and the Public Patent Foundation are seeking a ruling from the US Supreme Court on the validity of gene patents, according to an ACLU statement. The plaintiffs are asking for redress from the high court in their case against Myriad Genetics' patents on the BRCA1 and BRCA2 genes, after a federal appeals court ruled in August that those patents were valid.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.